Oppenheimer Downgrades Catalyst Pharmaceutical Partners (CPRX) to Perform
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.39 +0.03%
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 23
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 23
Join SI Premium – FREE
Oppenheimer analyst Leland Gershell downgraded Catalyst Pharmaceutical Partners (NASDAQ: CPRX) from Outperform to Perform.
For an analyst ratings summary and ratings history on Catalyst Pharmaceutical Partners click here. For more ratings news on Catalyst Pharmaceutical Partners click here.
Shares of Catalyst Pharmaceutical Partners closed at $30.52 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
- SentinelOne, Inc. (S) call put ratio 3.9 calls to 1 put with a focus on July 15 and 16 calls as share price up 3.4%
- Qualcomm (QCOM) June 26 weekly 200 and 230 calls active into investor meeting
Create E-mail Alert Related Categories
DowngradesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
